IBDEI1CK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21770,1,4,0)
 ;;=4^F17.291
 ;;^UTILITY(U,$J,358.3,21770,2)
 ;;=^5003376
 ;;^UTILITY(U,$J,358.3,21771,0)
 ;;=F17.290^^70^928^11
 ;;^UTILITY(U,$J,358.3,21771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21771,1,3,0)
 ;;=3^Nicotine Dependence,Oth Tobacco Product,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21771,1,4,0)
 ;;=4^F17.290
 ;;^UTILITY(U,$J,358.3,21771,2)
 ;;=^5003375
 ;;^UTILITY(U,$J,358.3,21772,0)
 ;;=F17.201^^70^928^12
 ;;^UTILITY(U,$J,358.3,21772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21772,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,In Remission
 ;;^UTILITY(U,$J,358.3,21772,1,4,0)
 ;;=4^F17.201
 ;;^UTILITY(U,$J,358.3,21772,2)
 ;;=^5003361
 ;;^UTILITY(U,$J,358.3,21773,0)
 ;;=F17.200^^70^928^13
 ;;^UTILITY(U,$J,358.3,21773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21773,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21773,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,21773,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,21774,0)
 ;;=F19.20^^70^928^17
 ;;^UTILITY(U,$J,358.3,21774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21774,1,3,0)
 ;;=3^Psycoactive Substance Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21774,1,4,0)
 ;;=4^F19.20
 ;;^UTILITY(U,$J,358.3,21774,2)
 ;;=^5003431
 ;;^UTILITY(U,$J,358.3,21775,0)
 ;;=F43.11^^70^928^14
 ;;^UTILITY(U,$J,358.3,21775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21775,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,21775,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,21775,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,21776,0)
 ;;=F43.12^^70^928^15
 ;;^UTILITY(U,$J,358.3,21776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21776,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,21776,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,21776,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,21777,0)
 ;;=F43.10^^70^928^16
 ;;^UTILITY(U,$J,358.3,21777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21777,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,21777,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,21777,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,21778,0)
 ;;=Z87.891^^70^928^4
 ;;^UTILITY(U,$J,358.3,21778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21778,1,3,0)
 ;;=3^Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,21778,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,21778,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,21779,0)
 ;;=F32.A^^70^928^3
 ;;^UTILITY(U,$J,358.3,21779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21779,1,3,0)
 ;;=3^Depression,Unspec
 ;;^UTILITY(U,$J,358.3,21779,1,4,0)
 ;;=4^F32.A
 ;;^UTILITY(U,$J,358.3,21779,2)
 ;;=^5161153
 ;;^UTILITY(U,$J,358.3,21780,0)
 ;;=L40.2^^70^929^1
 ;;^UTILITY(U,$J,358.3,21780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21780,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,21780,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,21780,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,21781,0)
 ;;=L03.91^^70^929^2
 ;;^UTILITY(U,$J,358.3,21781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21781,1,3,0)
 ;;=3^Acute Lymphangitis,Unspec
 ;;^UTILITY(U,$J,358.3,21781,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,21781,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,21782,0)
 ;;=L23.9^^70^929^3
 ;;^UTILITY(U,$J,358.3,21782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21782,1,3,0)
 ;;=3^Allergic Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,21782,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,21782,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,21783,0)
 ;;=L03.90^^70^929^4
